glp-1 drugs in pill form Health Canada approves first for high-risk type 2 diabetes patients Novo's Path To the First

To Use: Select an area of skin

The product also includes BCAAs, which not only support muscle endurance but also contribute to a healthier gut environment by supporting digestive health

Novo Nordisk (the maker

#Gastroenterology #PharmaInnovation #PatientCare #HealthcareIndia #Colozo #RegulatoryMilestone #ConstipationRelief #ChronicConstipation #ChronicConstipationManagement #GutHealthMatters #HealthcareInnovation #InclusiveHealthcare #FirstInClass #GoodHealthCantWait #WeAreDrReddys | 78 comments on LinkedIn

### Competing Interest Statement ASK, AMM, MCG, JMD, CB, CL, SWB, DJL, PML, DRD, JMC, JPF, YL, ARS, DAT, DWP, SH, RBR, MSL, and DAG are employees and stockholders of Pfizer Inc

Conclusions This open-label, single-center pilot study suggests that GLP-1-RAs are an effective and safe treatment option for achieving significant weight loss with a favorable effect on headache, leading to reduced acetazolamide dosage in pwIIH